Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 807

1.

Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.

Cropley VL, Fujita M, Bara-Jimenez W, Brown AK, Zhang XY, Sangare J, Herscovitch P, Pike VW, Hallett M, Nathan PJ, Innis RB.

Psychiatry Res. 2008 Jul 15;163(2):171-82. doi: 10.1016/j.pscychresns.2007.11.003. Epub 2008 May 27.

PMID:
18504119
[PubMed - indexed for MEDLINE]
2.

Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.

Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.

Arch Neurol. 1995 Dec;52(12):1183-90.

PMID:
7492293
[PubMed - indexed for MEDLINE]
3.

Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study.

Rinne JO, Portin R, Ruottinen H, Nurmi E, Bergman J, Haaparanta M, Solin O.

Arch Neurol. 2000 Apr;57(4):470-5.

PMID:
10768619
[PubMed - indexed for MEDLINE]
4.

Cortical 6-[18F]fluoro-L-dopa uptake and frontal cognitive functions in early Parkinson's disease.

Brück A, Aalto S, Nurmi E, Bergman J, Rinne JO.

Neurobiol Aging. 2005 Jun;26(6):891-8.

PMID:
15718048
[PubMed - indexed for MEDLINE]
5.

Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography.

Tiihonen J, Vilkman H, Räsänen P, Ryynänen OP, Hakko H, Bergman J, Hämäläinen T, Laakso A, Haaparanta-Solin M, Solin O, Kuoppamäki M, Syvälahti E, Hietala J.

Mol Psychiatry. 1998 Mar;3(2):156-61.

PMID:
9577840
[PubMed - indexed for MEDLINE]
6.

[(18)F]FDOPA and [(18)F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.

Rinne OJ, Nurmi E, Ruottinen HM, Bergman J, Eskola O, Solin O.

Synapse. 2001 Jun 1;40(3):193-200.

PMID:
11304757
[PubMed - indexed for MEDLINE]
7.

Dementia in Parkinson disease: functional imaging of cholinergic and dopaminergic pathways.

Hilker R, Thomas AV, Klein JC, Weisenbach S, Kalbe E, Burghaus L, Jacobs AH, Herholz K, Heiss WD.

Neurology. 2005 Dec 13;65(11):1716-22.

PMID:
16344512
[PubMed - indexed for MEDLINE]
8.

Imaging in Parkinson's disease: the role of monoamines in behavior.

Brooks DJ, Piccini P.

Biol Psychiatry. 2006 May 15;59(10):908-18. Epub 2006 Apr 11. Review.

PMID:
16581032
[PubMed - indexed for MEDLINE]
9.

'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.

Vernaleken I, Buchholz HG, Kumakura Y, Siessmeier T, Stoeter P, Bartenstein P, Cumming P, Gründer G.

Hum Brain Mapp. 2007 Oct;28(10):931-9.

PMID:
17133402
[PubMed - indexed for MEDLINE]
10.

Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.

Brück A, Aalto S, Nurmi E, Vahlberg T, Bergman J, Rinne JO.

Mov Disord. 2006 Jul;21(7):958-63.

PMID:
16550545
[PubMed - indexed for MEDLINE]
11.

Striatal FDOPA uptake and cognition in advanced non-demented Parkinson's disease: a clinical and FDOPA-PET study.

van Beilen M, Portman AT, Kiers HA, Maguire RP, Kaasinen V, Koning M, Pruim J, Leenders KL.

Parkinsonism Relat Disord. 2008;14(3):224-8. doi: 10.1016/j.parkreldis.2007.08.011. Epub 2008 Jan 14.

PMID:
18249027
[PubMed - indexed for MEDLINE]
12.

Relationship between nicotinic receptors and cognitive function in early Alzheimer's disease: a 2-[18F]fluoro-A-85380 PET study.

Ellis JR, Villemagne VL, Nathan PJ, Mulligan RS, Gong SJ, Chan JG, Sachinidis J, O'Keefe GJ, Pathmaraj K, Wesnes KA, Savage G, Rowe CC.

Neurobiol Learn Mem. 2008 Sep;90(2):404-12. doi: 10.1016/j.nlm.2008.05.006. Epub 2008 Jul 11.

PMID:
18620875
[PubMed - indexed for MEDLINE]
13.

Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia.

Yang YK, Yeh TL, Chiu NT, Lee IH, Chen PS, Lee LC, Jeffries KJ.

Psychiatry Res. 2004 Sep 15;131(3):209-16.

PMID:
15465290
[PubMed - indexed for MEDLINE]
14.

Baseline [18F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: A positron emission tomography study in healthy subjects.

Vernaleken I, Kumakura Y, Buchholz HG, Siessmeier T, Hilgers RD, Bartenstein P, Cumming P, Gründer G.

Neuroimage. 2008 Apr 15;40(3):1222-31. doi: 10.1016/j.neuroimage.2007.12.045. Epub 2008 Jan 8.

PMID:
18262797
[PubMed - indexed for MEDLINE]
15.

Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy.

Jokinen P, Brück A, Aalto S, Forsback S, Parkkola R, Rinne JO.

Parkinsonism Relat Disord. 2009 Feb;15(2):88-93. doi: 10.1016/j.parkreldis.2008.03.005. Epub 2008 Apr 22.

PMID:
18434233
[PubMed - indexed for MEDLINE]
16.

PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.

Laihinen AO, Rinne JO, Ruottinen HM, Någren KA, Lehikoinen PK, Oikonen VJ, Ruotsalainen UH, Rinne UK.

J Nucl Med. 1994 Dec;35(12):1916-20.

PMID:
7989969
[PubMed - indexed for MEDLINE]
Free Article
17.

Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.

Kumakura Y, Gjedde A, Danielsen EH, Christensen S, Cumming P.

J Cereb Blood Flow Metab. 2006 Mar;26(3):358-70.

PMID:
16079784
[PubMed - indexed for MEDLINE]
18.

Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.

Vernaleken I, Kumakura Y, Cumming P, Buchholz HG, Siessmeier T, Stoeter P, Müller MJ, Bartenstein P, Gründer G.

Neuroimage. 2006 May 1;30(4):1332-9. Epub 2006 Jan 24.

PMID:
16439159
[PubMed - indexed for MEDLINE]
19.

Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.

Carbon M, Ma Y, Barnes A, Dhawan V, Chaly T, Ghilardi MF, Eidelberg D.

Neuroimage. 2004 Apr;21(4):1497-507.

PMID:
15050574
[PubMed - indexed for MEDLINE]
20.

Striatal dopa and glucose metabolism in PD patients with freezing of gait.

Bartels AL, de Jong BM, Giladi N, Schaafsma JD, Maguire RP, Veenma L, Pruim J, Balash Y, Youdim MB, Leenders KL.

Mov Disord. 2006 Sep;21(9):1326-32.

PMID:
16721756
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk